The Journal of Organic Chemistry
Article
flash chromatography [hexanes, then hexanes/EtOAc (2:1)], com-
pound 18b was obtained as an intense yellow solid (36%).
Method B. Obtained from compound 14a (40 mg, 0.19 mmol) as
described in the general procedure (reaction time: 10 min).
Purification by flash chromatography [hexanes, then hexanes/EtOAc
(2:1)] gave compound 18b (19 mg, 31%).
9.6, 21.5, 27.5, 112.7, 120.4, 122.2, 123.7, 126.0, 127.3, 127.6, 127.7,
129.0, 131.3, 136.0, 140.8, 156.5, 165.4, 169.6; MS (EI) m/z: 345 (24)
[M]+, 186 (51), 172 (100), 157 (82), 130 (32), 102 (19), 77 (18);
HRMS (EI) m/z: calcd for C21H19N3O2 [M]+ 345.1477, found
345.1477; UV−vis (CH2Cl2) λ/nm (ε/M−1 cm−1) = 393 (5960).
3-Ethyl-4-(3-isopropyl-1H-indazol-1-yl)-1-methyl-1H-pyr-
role-2,5-dione (18g). Obtained from compound 14d (66 mg, 0.26
mmol) as described in the general procedure for method B (reaction
time: 15 min). Purification by flash chromatography [hexanes, then
hexanes/EtOAc (3:1)] gave compound 18g as a yellow oil (17 mg,
mp 193−195 °C (from hexanes/DCM) ; IR (KBr) 1714, 1679,
1
1495, 1449, 1382, 1348, 1120 cm−1; H NMR (400 MHz, CDCl3) δ
2.34 (s, 3H), 2.64 (s, 3H), 7.29 (pseudo-t, J = 7.6 Hz, 1H), 7.38
(pseudo-t, J = 7.0 Hz, 1H), 7.46−7.51 (m, 5H), 7.69−7.73 (m, 2H);
13C NMR (100 MHz, CDCl3) δ 9.8, 12.1, 112.5, 120.4, 122.5, 125.2,
1
22%). IR (film) 1713, 1653, 1434, 1402, 1018 cm−1; H NMR (400
MHz, CDCl3) δ 1.20 (t, J = 7.4 Hz, 3H), 1.46 (d, J = 6.8 Hz, 6H), 2.71
(q, J = 7.4 Hz, 2H), 3.12 (s, 3H), 3.42 (h, J = 6.8 Hz, 1H), 7.23−7.27
(m, 1H), 7.44 (pseudo-t, J = 7.8 Hz, 1H), 7.73−7.76 (m, 2H); 13C
NMR (100 MHz, CDCl3) δ 11.9, 16.3, 20.6, 23.0, 26.5, 111.6, 119.4,
121.1, 122.8, 126.6, 131.8, 134.7, 139.9, 155.3, 165.9, 169.8; MS (EI)
m/z: 297 (10) [M]+, 282 (100), 210 (13), 197 (17); HRMS (EI) m/z:
calcd for C17H19N3O2 [M]+ 297.1477, found 297.1479; UV−vis
(CH2Cl2) λ/nm (ε/M−1 cm−1) = 390 (5538).
126.1, 127.5, 127.8, 127.9, 129.1, 131.5, 135.8, 140.7, 148.0, 165.5,
169.7; MS (EI) m/z: 317 (39) [M]+, 288 (16), 260 (10), 197 (34),
169 (100), 102 (13); HRMS (EI) m/z: calcd for C19H15N3O2 [M]+
317.1164, found 317.1163; UV−vis (CH2Cl2) λ/nm (ε/M−1 cm−1) =
390 (5331).
3-Ethyl-1-methyl-4-(3-methyl-1H-indazol-1-yl)-1H-pyrrole-
2,5-dione (18c). Obtained from compound 14b (123 mg, 0.55
mmol) as described in the general procedure for method B (reaction
time: 15 min). Purification by flash chromatography [hexanes, then
hexanes/EtOAc (3:1)] gave compound 18c as a yellow oil (12 mg,
3-Ethyl-4-(3-isopropyl-1H-indazol-1-yl)-1-phenyl-1H-pyr-
role-2,5-dione (18h). Obtained from compound 14d (41 mg, 0.16
mmol) as described in the general procedure for method B (reaction
time: 15 min). Purification by flash chromatography [hexanes, then
hexanes/EtOAc (3:1)] gave compound 18h as a yellow oil (18 mg,
1
8%). IR (film) 1709, 1654, 1443, 1386, 1074 cm−1; H NMR (400
MHz, CDCl3) δ 1.17 (t, J = 7.6 Hz, 3H), 2.62 (s, 3H), 2.71 (q, J = 7.6
Hz, 2H), 3.12 (s, 3H), 7.25−7.28 (m, 1H), 7.46 (pseudo-t, J = 7.6 Hz,
1H), 7.65−7.69 (m 2H); 13C NMR (100 MHz, CDCl3) δ 12.1, 12.8,
17.3, 24.0, 112.2, 120.3, 122.2, 125.1, 127.8, 133.3, 135.3, 140.7, 147.6,
166.9, 170.7; MS (EI) m/z: 269 (10) [M]+, 254 (100), 182 (28), 169
(24), 143 (5); HRMS (EI) m/z: calcd for C15H15N3O2 [M]+
269.1164, found 269.1165; UV−vis (CH2Cl2) λ/nm (ε/M−1 cm−1)
= 386 (4329).
1
30%). IR (film) 1716, 1656, 1502, 1386 cm−1; H NMR (400 MHz,
CDCl3) δ 1.26 (t, J = 7.4 Hz, 3H), 1.49 (d, J = 6.9 Hz, 6H), 2.81 (q, J
= 7.4 Hz, 2H), 3.45 (h, J = 6.9 Hz, 1H), 7.24−7.28 (m, 1H), 7.38
(pseudo-t, J = 7.0 Hz, 1H), 7.42−7.51 (m, 5H), 7.75 (d, J = 8.0 Hz,
1H), 7.81 (d, J = 8.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 13.0,
17.6, 21.6, 27.6, 112.9, 120.5, 122.3, 124.0, 126.1, 127.7, 127.8, 129.1,
131.5, 132.6, 135.7, 141.0, 156.7, 165.7, 169.5; MS (EI) m/z: 359 (27)
[M]+, 344 (100), 239 (51), 210 (36), 197 (31); HRMS (EI) m/z:
calcd for C22H21N3O2 [M]+ 359.1634, found 359.1630; UV−vis
(CH2Cl2) λ/nm (ε/M−1 cm−1) = 395 (5391).
General Procedure for Generation and Pericyclic Reactions
of Benzo-2,3-diazafulvenium Methides under MW. A suspen-
sion of the appropriate 1,3-dihydrothiazolo[3,4-b]indazole-2,2-dioxide
14 (0.20 mmol) in 1,2,4-trichlorobenzene (0.5 mL) was irradiated in
the microwave reactor at 230 °C for the time indicated in each case.
After cooling to room temperature the product was isolated by flash
chromatography.
3-Methyl-2-vinyl-2H-indazole (21) and 3-methyl-1H-inda-
zole (22). Obtained from compound 14b (62 mg, 0.28 mmol) as
described in the general procedure (reaction time: 15 min).
Purification of the crude product by flash chromatography [hexanes,
then hexanes/EtOAc (2:1)] gave, in order of elution, 3-methyl-2-vinyl-
2H-indazole 21 as a colorless oil (14 mg, 32%) and 3-methyl-1H-
indazole 22 as a yellowish solid (6 mg, 16%).
3-Methyl-2-vinyl-2H-indazole (21). IR (film) 1645, 1627, 1358,
1284 cm−1; 1H NMR (400 MHz, CDCl3) δ 2.66 (s, 3H), 5.18 (d, J =
8.8 Hz, 1H), 6.14 (d, J = 15.2 Hz, 1H), 7.04 (pseudo-t, J = 7.6 Hz,
1H), 7.26−7.31 (m, 2H), 7.53 (d, J = 8.8 Hz, 1H), 7.63 (d, J = 8.8 Hz,
1H); 13C NMR (100 MHz, CDCl3) δ 9.8, 105.8, 117.4, 119.9, 121.1,
121.5, 127.5, 130.0, 131.4, 148.8; MS (EI) m/z: 158 (100) [M]+, 131
(32), 102 (11), 84 (14); HRMS (EI) m/z: calcd for C10H10N2 [M]+
158.0844, found 158.0849.
3-Ethyl-4-(3-methyl-1H-indazol-1-yl)-1-phenyl-1H-pyrrole-
2,5-dione (18d). Obtained from compound 14b (53 mg, 0.24 mmol)
as described in the general procedure for method B (reaction time: 15
min). Purification by flash chromatography [hexanes, then hexanes/
EtOAc (3:1)] gave compound 18d as an intense yellow solid (10 mg,
1
13%). mp 118−120 °C; IR (KBr) 1714, 1670, 1503, 1374 cm−1; H
NMR (400 MHz, CDCl3) δ 1.24 (t, J = 7.4 Hz, 3H), 2.64 (s, 3H), 2.81
(q, J = 7.4 Hz, 2H), 7.26−7.30 (m, 1H), 7.38 (pseudo-t, J = 6.8 Hz,
1H), 7.44−7.51 (m, 5H), 7.69 (d, J = 8.0 Hz, 1H), 7.73 (d, J = 8.4 Hz,
1H); 13C NMR (100 MHz, CDCl3) δ 11.1, 11.8, 16.5, 111.5, 119.3,
121.4, 124.2, 125.0, 126.8, 126.8, 128.1, 130.4, 131.9, 134.3, 139.7,
146.9, 164.6, 168.4; MS (EI) m/z: 331 (30) [M]+, 316 (100), 211
(65), 183 (67), 169 (50), 143 (15), 102 (10); HRMS (EI) m/z: calcd
for C20H17N3O2 [M]+ 331.1321, found 331.1322; UV−vis (CH2Cl2)
λ/nm (ε/M−1 cm−1) = 393 (4953).
3-(3-Isopropyl-1H-indazol-1-yl)-1,4-dimethyl-1H-pyrrole-
2,5-dione (18e). Obtained from compound 14c (80 mg, 0.34 mmol)
as described in the general procedure for method B (reaction time: 10
min). After purification by flash chromatography [hexanes, then
hexanes/EtOAc (3:1)], compound 18e was obtained as an intense
yellow solid (38 mg, 38%). mp 97−99 °C (from diethyl ether/
1
hexanes); IR (KBr) 1705, 1651, 1387, 1074 cm−1; H NMR (400
MHz, CDCl3) δ 1.47 (d, J = 7.0 Hz, 6H), 2.26 (s, 3H), 3.13 (s, 3H),
3.43 (h, J = 7.0 Hz, 1H), 7.24−7.27 (m, 1H), 7.45 (pseudo-t, J = 7.6
Hz, 1H), 7.72 (d, J = 8.8 Hz, 1H), 7.75 (d, J = 8.0 Hz, 1H); 13C NMR
(100 MHz, CDCl3) δ 9.5, 21.7, 24.1, 27.6, 112.6, 120.5, 122.2, 123.7,
127.6, 127.7, 136.2, 140.9, 156.3, 166.8, 171.1; MS (EI) m/z: 283
(100) [M]+, 268 (56), 252 (36), 198 (75), 183 (49), 155 (28), 102
(26); HRMS (EI) m/z: calcd for C16H17N3O2 [M]+ 283.1321, found
283.1319; UV−vis (CH2Cl2) λ/nm (ε/M−1 cm−1) = 388 (5845).
3-(3-Isopropyl-1H-indazol-1-yl)-4-methyl-1-phenyl-1H-pyr-
role-2,5-dione (18f). Obtained from compound 14c (74 mg, 0.31
mmol) as described in the general procedure for method B (reaction
time: 10 min). After purification by flash chromatography [hexanes,
then hexanes/EtOAc (2:1)], compound 18f was obtained as an
intense yellow solid (48 mg, 45%). mp 145−146 °C (from diethyl
3-Methyl-1H-indazole (22). The indazole 22 was identified by
comparison with a specimen previously described in the literature.9 mp
102−103 °C (from hexanes/diethyl ether), lit.9 113 °C. 1H NMR (400
MHz, CDCl3) δ 2.60 (s, 3H), 7.15 (pseudo-t, J = 7.4 Hz, 1H), 7.36−
7.44 (m, 2H), 7.69 (d, J = 8.0 Hz, 1H).
2-Methyl-3-(prop-1-en-2-yl)-2H-indazole (23a). Obtained
from compound 14c (50 mg, 0.21 mmol) as described in the general
procedure (reaction time: 10 min). After purification by flash
chromatography [hexanes, then hexanes/EtOAc (1:1)], compound
23a was obtained as an oil (21 mg, 58%). IR (film) 1622, 1486, 1357,
1
1286, 1040 cm−1; H NMR (400 MHz, CDCl3) δ 2.25 (s, 3H), 4.16
1
ether); IR (KBr) 1712, 1673, 1506, 1382, 1120 cm−1; H NMR (400
(s, 3H), 5.26 (s, 1H), 5.60 (s, 1H), 7.06 (pseudo-t, J = 7.4 Hz, 1H),
7.25−7.27 (m, 1H), 7.60 (d, J = 8.4 Hz, 1H), 7.65 (d, J = 8.8 Hz, 1H);
13C NMR (100 MHz, CDCl3) δ 23.1, 38.6, 116.9, 120.3, 120.5, 121.3,
MHz, CDCl3) δ 1.50 (d, J = 6.9 Hz, 6H), 2.36 (s, 3H), 3.46 (h, J = 6.9
Hz, 1H), 7.26−7.29 (m, 1H), 7.40 (pseudo-t, J = 7.2 Hz, 1H), 7.43−
7.52 (m, 5H), 7.76−7.79 (m, 2H); 13C NMR (100 MHz, CDCl3) δ
635
dx.doi.org/10.1021/jo302463q | J. Org. Chem. 2013, 78, 628−637